Under terms of the deal, Pfizer will gain rights to develop, manufacture, and commercialize SSGJ-707 outside of China.

Leandro Boer, MD, PhD, VP, US general medicines, Amgen, discusses the company's nationwide push to reduce cardiovascular risk ...

Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.

The ability to predict side effects such as nausea before starting treatment represents a paradigm shift in precision ...

Deal includes 23andMe’s Biobank, Personal Genome Service, Total Health, and research services operations.

Acquisition includes INZ-701, a late-stage enzyme replacement therapy targeting ectonucleotide ...

PE: How can digital solutions address gaps in women’s healthcare? Partridge: Digital solutions play a crucial role in ...

Leandro Boer, MD, PhD, VP, US general medicines, Amgen, explains why seamless communication and treatment continuity across ...

Jørgensen will step down after eight years as CEO, with a successor search underway while the company reaffirms confidence in ...

The decision follows ongoing investigations into serious adverse events primarily reported in elderly individuals who ...

Welireg marks the first FDA-approved non-surgical treatment option for locally advanced, unresectable, or metastatic ...

Polanco, executive VP and chief commercial officer, Novartis US, and the 2025 Healthcare Businesswomen’s Association Woman of ...